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for Haemodialysis
J.H.M. Tordoir,1* X. Keuter,1 N. Planken,1 M.W. de Haan2 and F.M. van der Sande3Departments of 1Surgery, 2Radiology, and 3Nephrology, University Hospital Maastricht,
Maastricht, The NetherlandsObjectives: The world’s haemodialysis population is growing rapidly so that in 2006, some 1.5 million interventions will be
needed for access placement, revision and maintainance. Secondary and tertiary arteriovenous fistulas are becoming an
integral part of vascular access especially in the elderly, comorbid population.
Methods: Venous conduits may have a more favourable outcome with fewer complications and revisions in comparison with
accesses using prosthetic implants. Innovative surgical techniques, including vein transposition, translocation and elevation
may add to this philosophy of creating exclusively autogenous vascular access..
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For decades the strategies for access creation have
been different in Europe and the USA with the
majority of new and incident patients receiving
autogenous arteriovenous fistulas (AVF) in Europe,
whereas in the USA most have received prosthetic
grafts. Although there is still a clear preference for
primary autogenous radial-cephalic arteriovenous
fistulas (RCAVF) in European countries, the need
for secondary and tertiary procedures in Europe is
increasing due the increasing age of dialysis patients
and associated comorbidities such as diabetes
mellitus, coronary artery disease and peripheral
arterial disease, which may hamper the creation of
autogenous vascular access conduits. Recently pub-
lished data still show a high prevalence of auto-
genous AVFs among European patients, but there
seems to be a major shift in secondary and tertiary
procedures from forearm fistulas to elbow and upper
arm fistulas.1 In addition, the difficulties encounteredenal Access and Transplantation—one of a series of
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vascular access has led to a renewed interest in the
exclusive use of the patient’s own veins for fistula
creation.
In this review the strategies, surgical techniques
and outcomes of the creation of secondary and tertiary
accesses with the use of upper and lower extremity
venous conduits are described.Secondary/Tertiary Autogenous Fistulas in the
Upper Extremity
The upper limb is preferred over the lower extremity
for vascular access because of the ease of cannulation,
comfort for the patient and the considerably lower
incidence of complications. Similarly, autogenous
conduits are also preferable to the use of prosthetic
grafts because of improved patency and lower risk of
infection.Forearm venous transposition and elevation
Superficial vein transposition increases the possibili-
ties for forearm fistulas. When the cephalic vein is
unsuitable the basilic vein can be transposed from theEur J Vasc Endovasc Surg 31, 661–666 (2006)
doi:10.1016/j.ejvs.2005.10.005, available online at http://www.sciencedirect.com onved.
Fig. 1. Brachial-cubital AVF (Gracz). BA, brachial artery; PV,
perforating vein; CV, cephalic vein.
J. H. M. Tordoir et al.662ulnar to the radial side along a straight subcutaneous
course from the elbow to the radial artery. Silva et al.2
advocated different surgical techniques, according to
the forearm artery and vein location. Of the 89 veins
that were of acceptable size and patency, 13 (15%) were
in immediate proximity to the radial artery such that
an AVF could be formed through a single incision.
Thirty of 89 (33%) of the veins were located on the
dorsal aspect of the forearm and were transposed to
the volar aspect for anastomosis to the appropriate
artery (radial in 26, ulnar in two, and brachial in two).
The remaining 46 of 89 veins (52%) were located on the
volar aspect of the forearm but were dissected through
separate incisions, transposed superficially, and
sutured to the appropriate artery (radial in 42, ulnar
in two, and brachial in two). Successful cannulation
and hemodialysis was accomplished in 81 of the 89
AVFs, giving a maturation rate of 91%. Primary
patency rates were 84% at 1 year and 69% at 2 years
for all AVFs.
When the arterial inflow into a radial fistula is
impeded by a distal stenosis in the forearm, it may be
enhanced by transposition of the forearm cephalic or
basilic vein more proximally to the radial artery or
brachial artery at the elbow in a subcutaneous loop.3
A cephalic vein that is located too deeply may be
made accessible for cannulation by elevation. Four to 9
weeks after the initial operation, the cephalic vein has
usually matured sufficiently to allow easy surgical
dissection. The subcutaneous fat is approximated
beneath the fistula vein, thereby elevating the fistula
to a superficial position. An alternative surgical option
is cephalic vein dissection and transection 2 cm
proximal to the AV anastomosis with subcutaneous
rerouting along a straight course with reanastomosis
to the radial artery. The elevation technique has been
described by Cull et al. in seven patients with RCAVFs
and cannulation difficulties. The failure rate was rather
high with five out of seven elevated fistulas non-
functional for dialysis treatment.4Mid-forearm and elbow AVF
When the arteries and/or veins are too small or
diseased for the creation of a wrist RCAVF, more
proximally located fistulas are indicated with an
anastomosis at the mid-forearm or elbow region.
Konner et al. have shown that in a high percentage of
patients with failed RCAVFs still a suitable vein can be
found proximal in the forearm, which can be
anastomosed to the radial artery.5 Bonforte et al. have
described the surgical technique of mid-forearm
fistula. A total of 112 surgical procedures wereEur J Vasc Endovasc Surg Vol 31, June 2006performed on 106 patients with primary 24- and 48-
month patency rates of 93 and 83%, respectively, and a
low incidence of complications.6
In brachial-cubital AVFs (Gracz fistula), the deep
perforating branch of the medial cubital vein is
dissected, transected and anastomosed to the brachial
or proximal radial artery (Fig. 1). The flow through the
AVF will be directed either to the upper arm basilic
and/or cephalic vein, which becomes available for
cannulation. Brachial-cubital AVFs generate a high
blood flow for dialysis. The incidences of non-
maturation, thrombosis and infection are low with
good long-term patency. In 50 patients with brachio-
cubital AVFs, the 1- and 3-year patencies were 84 and
78%, respectively. Major complications were distal
hypoperfusion, which may lead to symptomatic hand
ischaemia, and high-output cardiac failure, especially
in patients with heart disease and coronary artery
sclerosis.7Upper arm brachial-cephalic AVF
The brachial-cephalic AV fistula is only one of a variety
of possible AV anastomoses in the elbow region.
Depending on the individual situation, the proximal
radial artery, brachial arteryor proximal ulnar artery can
be used for the AV anastomosis (Fig. 2). As for forearm
fistulas, the vascular access should provide an optimal
situation for cannulation along the cephalic vein.
Recently, the results of 100 brachial-cephalic fistulas
in 96 patients were reported, with the majority of
patients receiving a brachial artery to cubital vein
Fig. 2. Brachial-cephalic AVF. BA, brachial artery; CV,
cephalic vein.
Fig. 3. Brachial-basilic AVF. 1, basilic vein in its normal
position; 2, brachial artery; 3, transposed basilic vein.
Secondary and Tertiary Access 663anastomosis. The primary, primary assisted, and
secondary patency rates after 1 year were 54.7, 72.3
and 79.2%, and after 2 years 40.4, 59.2 and 67.5%,
respectively. Predictors of failure, using Cox regression
multivariate analysis, included diabetes mellitus (HR
2.81, p!0.001) and a history of contralateral PTFE loop
graft (HR 7.79, pZ0.007). The authors concluded that
the primary patency of brachial-cephalic fistulas was
comparable to that of radial-cephalic fistulas.8
Reported early failure and 1-year patency rates of
brachial-cephalic AVFs are outlined in Table 1.8–13Upper arm brachial-basilic AVF
Usually the upper arm basilic vein is inaccessible
for dialysis cannulation, because of its medial and
deep native position. In 1976, Dagher et al.14
described the original technique of brachial-basilic
anastomosis with a second operation to mobilise the
arterialised vein into a subcutaneous position. There
are several surgical options for brachial-basilic AVFs
(BBAVF):Table 1. Early failure and 1-year patency of brachial-cephalic AVFs
Author No AVFs Early failure (%) Patency (%)
Dunlop et al.9 81 – 70
Zibari et al.10 48 – 90
Nazzal et al.11 42 – 91
Murphy et al.12 208 16 75
Zeebregts et al.8 100 11 79
Lok et al.13 186 9 78† One-stage procedure: The basilic vein is dissected
and side branches ligated from the elbow to the
axilla. After transection at the elbow it is
transposed through a lateral subcutaneous tunnel
and reanastomosed end-to-side to the brachial
artery (Fig. 3).
† Two-stage procedure: At the first operation a
brachial artery to basilic vein anastomosis is
performed. Six weeks later a second procedure is
performed using one of two alternative tech-
niques for superficialisation of the vein:
(a) Elevation: The basilic vein is dissected and
the side branches ligated. The fat is sutured
beneath the vein, elevating it to a subcu-
taneous position.
(b) Transposition: The basilic vein is dissected
out, the sidebranches ligated and transected
2 cm proximal to the AV anastomosis. It is
then passed laterally through a subcutaneous
tunnel and reanastomosed to the brachial
artery.
No significant differences in non-maturation and
patency rates have been reported between one and
two-stage procedures. The elevation and transposition
techniques also have similar outcomes. Rivers et al.15
found that 49% of one stage BBAVFs were patent at 30
months. Hossny16 employed the different techniques
of BBAVF creation in a non-randomised study of 70
patients. High one-year patencies from 86 to 90% in all
groups were reported with only 5–7% of AVF showing
non-maturation. Recent publications report a primary
failure rate of 5–40% with 1-year patencies varying
from 47 to 90% (Table 2).15–23 The technique ofEur J Vasc Endovasc Surg Vol 31, June 2006
Table 2. Early failure and 1-year patency of brachial-basilic AVFs
Author Type
AVF
No.
AVFs
Early
failure (%)
Patency
(%)
Rivers et al.15 os/tr 65 2 58
Coburn et al.17 os/tr 59 – 93
El Mallah et al.18 os/tr 20 40 50
ts/el 20 10 80
Humphries et al.19 ts/el 67 – 84
Murphy et al.20 os/tr 74 32 73
Segal et al.21 os/tr 99 23 64
Taghizadeh et al.22 os/tr 75 8 66
Hossny16 os/el 20 5 90
os/tr 20 7 86
ts/el 30 5 87
Rao et al.23 os/tr 56 38 47
Os, one stage; Ts, two stage; Tr, transposition; El, elevation.
J. H. M. Tordoir et al.664subcutaneous placement of the basilic vein seems to
have several advantages over forearm or upper arm
graft implantation, with less infection and thrombosis.
In comparison with brachial-cephalic fistulas, BBAVFs
are more likely to mature, although they are more
susceptible to late thrombosis.Upper arm brachial-brachial vein AVF
Recently a transposition fistula using the brachial vein
in the upper arm has been described for vascular
access in two patients.24 As in basilic vein trans-
position, the brachial vein is harvested distally about
3 cm into the forearm beyond the antecubital fossa, in
order to gain sufficient length for lateral tunnelling.
The vein is ligated at this level, transected and
transposed through a subcutaneous tunnel lateral to
the incision. The non-distended brachial vein is about
4–5 mm in diameter and may increase to 6–8 mm
under pressure. A period of 8 weeks is allowed for the
fistula to mature prior to its use for haemodialysis.Upper arm brachial-axillary translocated superficial
femoral vein
The superficial femoral vein is a large autogenous vein
that can be translocated to the upper extremity. It is
exposed through an incision that extends from the
inferior aspect of the femoral triangle over the
common femoral vein to the above-knee popliteal
fossa on the lateral aspect of the sartorius muscle. The
superficial femoro-popliteal vein is then dissected free
caudally from its confluence with the profunda
femoral vein to the midpopliteal fossa. After removal,
the reversed vein is interposed through a subcu-
taneous tunnel between the brachial artery and
axillary vein. Huber et al.25 reported on the outcome
of 30 superficial femoral vein (SFV) translocations.Eur J Vasc Endovasc Surg Vol 31, June 2006The primary, primary assisted, and secondary patency
rates for the SFV were 79, 91, and 100%, respectively, at
12 months; and 67, 86, and 100%, respectively, at 18
months. Significant hand ischaemia developed in 43%
of the patients and required a DRIL procedure in 27%.
Thigh wound complications developed in 23% of the
patients, and arm wound complications developed in
17%. There was a significant difference in the incidence
of thigh complications between obese and non-obese
patients (57 vs. 13%). One patient with PAOD required
an above-knee amputation ipsilateral to the deep vein
harvest, and a second patient with a failing DRIL
procedure required a finger amputation.Secondary/Tertiary Autogenous Fistulas in the
Lower Extremity
The lack of potential upper extremity or chest wall
AVF sites, due to exhaustion of all upper extremity
outflow veins by catheter-induced central venous
obstruction, makes vascular access at the femoral
region inevitable for a growing number of patients.
Saphenous and superficial femoral vein transposition
are options for thigh AVFs.Lower extremity femoral-greater saphenous vein access
The greater saphenous vein can be used for vascular
access in either of two ways:
† It may be transposed in a straight subcutaneous
tunnel with anastomosis to the superficial femoral
artery above the knee. The main advantage of this
technique is its long subcutaneous course available
for cannulation.26
† The second surgical option is transposition in a
looped fashion with the AV anastomosis to the
groin femoral artery.Lower extremity femoral-superficial femoral vein access
Gradman et al.27 have described the technique of
superficial femoral vein (SFV) transposition. The
superficial femoral vein, in continuity with a variable
length of supragenicular popliteal vein, is mobilized
from the popliteal fossa to the junction of the femoral
vein with the profunda femoris vein. The vein is
transposed superficially and anastomosed to the distal
femoral artery (Fig. 4). The vein is usually suture
banded primarily to avoid distal ischaemia due to
steal from the high fistula flow.
Fig. 4. Superficial femoral vein transposition. SFA, superficial femoral artery; SFV, superficial femoral vein.
Secondary and Tertiary Access 665The results of elective construction of a SFV fistula
were reported in 54 patients.27 The first patients
underwent intraoperative access banding and when
indicated a femoropopliteal bypass graft or a composite
prosthetic-femoral vein to groin femoral artery looped
access was performed in patients with peripheral
arterial obstructive disease (PAOD). More recently,
patients with known PAOD were excluded. Patients
without PAOD that were included underwent a variety
of measures to avoid ischaemia, including tapering of
the femoral vein at the takeoff from the distal femoral
arteryandcompartment fasciotomieswhenpulseswere
very weak or absent immediately after access construc-
tion. In the total patient group, 10 accesseswere banded
either intraoperatively (6) or in the immediate post-
operative period (4) to avoid or treat ischaemia. Nine
patients (16%) showed evidence of ischaemia in the
postoperative period. Procedures to alleviate ischaemia
included various combinations of distal bypasswithout
interval ligation, conversion to a looped access, iliac
artery angioplasty, fasciotomy, access banding, and
access ligation. One patient eventually had an above-
knee amputation. In this study no major wound
complications or graft infections were reported. How-
ever, in another study there was a rather high incidence
of ischaemia and infection (30 and 27%, respectively).28Summary
† The percentage of autogenous vascular access in
elderly, comorbid and obese patients can be
increased considerably by innovative surgical
procedures, including elevation and/or trans-
position of deeply or dorsally positioned veins.
† Upper extremity secondary/tertiary autogenous
access conduits with transposed veins havepatency rates comparable to primary radial-cepha-
lic AVFs.
† The surgical technique of brachial-basilic AVF (one
vs. two-stage procedure; vein transposition vs.
elevation) results in similar non-maturation and
1-year patency rates.
† Lower extremity access by femoral vein trans-
position is an acceptable alternative in case of
upper extremity outflow obstruction, but exhibits a
high incidence of ischaemia and infection.References
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